ci 994 has been researched along with Devic Disease in 1 studies
tacedinaline: oral cytostatic drug with impressive differential activity against leukemic cells & normal stem-cells
tacedinaline : A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our research provided evidence supporting the lower-dose RTX strategy in treating NMOSD and reopened the issues of optimal dosage and therapy initiation timing." | 1.91 | Rituximab at lower dose for neuromyelitis optica spectrum disorder: a multicenter, open-label, self-controlled, prospective follow-up study. ( Bai, M; Guo, J; Lei, T; Li, H; Li, Z; Liu, Z; Lu, J; Ma, C; Ren, K; Wu, J; Wu, S; Xu, Z; Zhao, D; Zhao, S, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, D | 1 |
| Ren, K | 1 |
| Lu, J | 1 |
| Liu, Z | 1 |
| Li, Z | 1 |
| Wu, J | 1 |
| Xu, Z | 1 |
| Wu, S | 1 |
| Lei, T | 1 |
| Ma, C | 1 |
| Zhao, S | 1 |
| Bai, M | 1 |
| Li, H | 1 |
| Guo, J | 1 |
1 other study available for ci 994 and Devic Disease
| Article | Year |
|---|---|
Rituximab at lower dose for neuromyelitis optica spectrum disorder: a multicenter, open-label, self-controlled, prospective follow-up study.
Topics: Drug-Related Side Effects and Adverse Reactions; Follow-Up Studies; Humans; Neuromyelitis Optica; Pr | 2023 |